Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
The only current strategy to test efficacy of novel interventions for sustained HIV control without antiretroviral therapy (ART) among people with HIV (PWH) is through an analytical treatment interruption (ATI). Inclusion of ‘placebo’ controls in ATIs poses ethical, logistical, and economic challeng...
Κύριοι συγγραφείς: | Gunst, JD, Gohil, J, Li, JZ, Bosch, RJ, White, Catherine Seamon, A, Chun, T, Mothe, B, Gittens, K, Praiss, L, De Scheerder, M, Vandekerckhove, L, Escandón, K, Thorkelson, A, Schacker, T, SenGupta, D, Brander, C, Papasavvas, E, Montaner, LJ, Martinez-Picado, J, Calin, R, Castagna, A, Muccini, C, de Jong, W, Leal, L, Tipoe, T, Frater, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
Nature Research
2025
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Time to HIV viral rebound and frequency of post-treatment control after analytical interruption of antiretroviral therapy: an individual data-based meta-analysis of 24 prospective studies
ανά: Jesper D. Gunst, κ.ά.
Έκδοση: (2025-01-01) -
To rebound or not to rebound
ανά: Bethany A Stahl, κ.ά.
Έκδοση: (2017-10-01) -
Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption
ανά: Leila B. Giron, κ.ά.
Έκδοση: (2021-02-01) -
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
ανά: Hurst, J, κ.ά.
Έκδοση: (2015) -
Operational complexity and supplier-customer integration: case study insights and complexity rebound.
ανά: Sivadasan, S, κ.ά.
Έκδοση: (2010)